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ABSTRACT:  1 
SynGAP is a Ras/Rap GTPase-activating protein (GAP) present in high concentration in postsynaptic 2 
densities (PSDs) from mammalian forebrain where it binds to all three PDZ (PSD-95, Discs-large, ZO-1) 3 
domains of PSD-95. We show that phosphorylation of synGAP by Ca2+/calmodulin-dependent protein 4 
kinase II (CaMKII) decreases its affinity for the PDZ domains as much as 10-fold, measured by surface 5 
plasmon resonance. SynGAP is abundant enough in postsynaptic densities (PSDs) to occupy about one 6 
third of the PDZ domains of PSD-95. Therefore, we hypothesize that phosphorylation by CaMKII reduces 7 
synGAP’s ability to restrict binding of other proteins to the PDZ domains of PSD-95. We support this 8 
hypothesis by showing that three critical postsynaptic signaling proteins that bind to the PDZ domains of 9 
PSD-95 are present at a higher ratio to PSD-95 in PSDs isolated from synGAP heterozygous mice.   10 
Introduction 11 
The postsynaptic density (PSD) is an organized complex of signaling proteins attached to the 12 
postsynaptic membrane of excitatory glutamatergic synapses in the central nervous system. It comprises a 13 
network of scaffold proteins, the most prominent of which is PSD-95, a member of the MAGUK family 14 
(Membrane-Associated GUanylate Kinase-like proteins) (Kennedy, 2000). PSD-95 contains three PDZ 15 
domains that bind transmembrane receptors and cytosolic signaling proteins by attaching to four to seven 16 
residue sequences usually located at the C-terminus of the binding protein (Fig. 1A; Kornau et al., 1995; 17 
Kornau et al., 1997). PSD-95 associates with itself and other scaffold proteins via its guanylate kinase-18 
like domain to form an interconnected network that spatially organizes receptors and biochemical signal 19 
transduction machinery at the postsynaptic site (Baron et al., 2006; Sheng and Kim, 2011).  20 
Formation and modulation of excitatory synapses involves de novo assembly and/or re-arrangement of 21 
the proteins bound to PDZ domains of PSD-95 and other binding sites on the PSD scaffold (El-Husseini et 22 
al., 2000; Steiner et al., 2008; Sturgill et al., 2009). One class of glutamate receptor channels, NMDA-type 23 
glutamate receptors (NMDARs) bind directly to PDZ domains of PSD-95 via their cytosolic C-termini 24 
(Kornau et al., 1995). A second class, AMPARs, bind indirectly to PDZ domains of PSD-95 through two 25 
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families of auxiliary subunits, TARPs (Transmembrane AMPA Receptor Regulatory Proteins) (Tomita et 26 
al., 2005) and LRRTMs (Leucine-Rich Repeat TransMembrane proteins) (de Wit et al., 2009). AMPARs, 27 
NMDARs, TARPs, and LRRTMs, along with the synaptic organizing molecule neuroligin, comprise the 28 
most highly enriched transmembrane proteins precipitated together with PSD-95 from the postsynaptic 29 
density fraction of mouse forebrain (Dosemeci et al., 2007).  LRRTMs and neuroligin bind to presynaptic 30 
neurexin, which promotes formation of new presynaptic vesicle release sites (Siddiqui et al., 2010). 31 
A smaller number of cytosolic signaling proteins also associate directly with PDZ domains of PSD-95 32 
(Brenman et al., 1996; Chen et al., 1998; Kim et al., 1998; Murphy et al., 2006; Sakagami et al., 2008). 33 
Among these, the synaptic Ras/Rap GTPase activating protein synGAP is particularly interesting for 34 
several reasons. It is unusually abundant in the PSD fraction; indeed, it is nearly as abundant in PSD-95 35 
complexes as PSD-95 itself (Chen et al., 1998; Cheng et al., 2006; Dosemeci et al., 2007). The synGAP 36 
gene displays a highly penetrant gene-dosage effect. Heterozygous deletion of synGAP in mice or 37 
humans produces a pronounced cognitive deficit (Komiyama et al., 2002; Hamdan et al., 2009; Hamdan 38 
et al., 2011; Berryer et al., 2013). This means that the amount of the synGAP protein is rate-limiting for at 39 
least one critical process at the synapse. Finally, the carboxyl tails of two prominent synGAP splice 40 
variants bind to all three of the PDZ domains of PSD-95 in yeast two hybrid assays (Kim et al., 1998). In 41 
contrast, most other PSD-95 binding proteins bind specifically either to PDZ domains 1 and 2, or to PDZ3 42 
(e.g. Kornau et al., 1995; Irie et al., 1997). Taken together, these characteristics suggest that synGAP 43 
occupies a particularly large proportion of the PDZ domains of PSD-95 in most excitatory synapses; 44 
therefore, a 50% reduction in the amount of synGAP available to bind to PSD-95 might have pathological 45 
consequences for synaptic function.  46 
Mutations in a single copy of synGAP have been causally implicated in ~ 9% of cases of non-47 
syndromic cognitive impairment associated with either autism (ASD) or epilepsy (Berryer et al., 2013). 48 
Studies of the effects of such mutations in mice suggest a possible underlying neural mechanism. 49 
Deletion of synGAP in cultured hippocampal neurons results in precocious formation of excitatory 50 
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synapses. Enlarged postsynaptic spines containing clusters of PSD-95 develop in mutant neurons two 51 
days before they develop in wild-type neurons; and the precocious synapses contain a larger number of 52 
AMPARs (Vazquez et al., 2004). Early maturation of synapses in mice with a heterozygous deletion of 53 
synGAP shortens the critical period for experience-dependent synaptic development in the cortex 54 
(Clement et al., 2013). A corresponding shortening of the critical period in humans may underlie 55 
malformation of circuits with resulting cognitive impairment, autism, and/or epilepsy.  56 
In mutant mouse neurons with a homozygous synGAP deletion, viral expression of recombinant wild-57 
type synGAP reverses the precocious synapse formation (Vazquez et al., 2004). Spine heads enlarge and 58 
PSD-95 clusters enter synaptic spines at the normal time. In contrast, expression of synGAP lacking the 59 
five-residue C-terminal PDZ domain ligand (∆SXV) does not reverse the phenotype. Indeed, we observed 60 
that, after expression of ∆SXV, the sizes of clusters of PSD-95 are larger than in the deletion mutant itself 61 
and continue to enter the spine earlier than in wild-type neurons. SynGAP bearing the ∆SXV mutation 62 
localizes normally to spines indicating that failure to rescue the phenotype is not caused by abnormal 63 
localization. This observation led us to hypothesize that binding of synGAP to the PDZ domains of PSD-64 
95 might normally restrict the binding of other proteins that influence clustering of PSD-95 and its 65 
movement into the spine. Recent work suggests that those proteins could include neuroligins (Sudhof, 66 
2008), LRRTMs (Siddiqui et al., 2010) or TARPs (Tomita et al., 2005).  67 
Phosphorylation of synGAP by CaMKII has recently been shown to induce movement of synGAP out 68 
of the PSD in living neurons (Yang et al., 2013; Araki et al., 2015). In our recent study of 69 
phosphorylation sites for CaMKII on r-synGAP, a soluble recombinant form of synGAP missing the first 70 
100 N-terminal residues, we found one site (S1283) located very near the C-terminal PDZ domain ligand 71 
(Fig. 1A; Walkup IV et al., 2015). Therefore, we tested whether phosphorylation of this site or others by 72 
CaMKII reduces the affinity of synGAP for PDZ domains of PSD-95. Here we demonstrate that 73 
phosphorylation of several sites in the disordered domain of synGAP and of S1283 dramatically reduces 74 
binding of synGAP to all of the PDZ domains on PSD-95. We also report the unexpected finding that the 75 
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disordered domain of synGAP binds Ca2+/CaM with high affinity and this binding causes a smaller 76 
reduction of affinity of synGAP for PDZ3. We hypothesize that phosphorylation of synGAP in the PSD, 77 
triggered by activation of NMDARs, could substantially reduce the ability of synGAP to compete with 78 
other proteins for binding to the PDZ domains of PSD-95, permitting increased equilibrium binding of 79 
neuroligin, TARPs and/or LRRTMs. We support the hypothesis that binding of synGAP to PSD-95 80 
restricts binding of other proteins by showing that the number of TARPs, LRRTM2, and neuroligin-2 81 
molecules per molecule of PSD-95 is significantly increased in PSD fractions isolated from mice with a 82 
heterozygous deletion of synGAP compared to those isolated from wild type mice.  83 
We propose that reconfiguration of the PSD triggered by phosphorylation of synGAP and the 84 
resulting decrease in its affinity for PDZ domains of PSD-95 facilitates formation of new synapses and/or 85 
leads to strengthening of existing synapses in part by allowing increased trapping of AMPARs in the PSD 86 
during the early stages of induction of long-term potentiation (LTP; Opazo and Choquet, 2011). This 87 
proposed mechanism is consistent with the “slot” hypothesis for addition of new AMPA-receptors during 88 
induction of LTP (Shi et al., 2001; Henley and Wilkinson, 2016), and we discuss how it can account for 89 
many previous experimental observations. 90 
Results 91 
Phosphorylation of R-synGAP by CaMKII Reduces Its Binding to PDZ Domains of PSD-95–  SynGAP 92 
can be expressed in bacteria and purified in a soluble form by deleting the first 102 residues of its N-93 
terminus (Walkup IV et al., 2015).  This version of synGAP, termed r-synGAP, retains all of the 94 
identified functional domains, the “disordered” regulatory domain, and the C-terminal PDZ ligand (Fig. 95 
1A).  In a previous study we showed that r-synGAP is phosphorylated by CaMKII at several residues 96 
including S1283, which is 7 residues upstream of the PDZ domain ligand located at residues 1290-1293 97 
(Walkup IV et al., 2015). Because this phosphorylation site is so near the PDZ ligand, we wondered 98 
whether its phosphorylation, or phosphorylation of other sites by CaMKII, would interfere with binding 99 
of synGAP to PDZ domains of PSD-95. To test this, we incubated r-synGAP with affinity resins 100 
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substituted with recombinant PDZ domains as described under Materials and Methods. The beads 101 
contained PDZ1 (61-151), PDZ2 (155-249), PDZ3 (302-402), a fragment containing PDZ1 and PDZ2 102 
(PDZ12, 61-249), or a fragment containing all three PDZ domains (PDZ123, 61-402). Binding of r-103 
synGAP to the beads was tested with or without a prior 10 min phosphorylation by CaMKII. As expected, 104 
without phosphorylation, r-synGAP binds specifically to each of the three PDZ domains (Fig. 1B). In this 105 
assay, its binding is highest to PDZ3. Binding of r-synGAP to PDZ123 reveals a substantial avidity 106 
effect; that is, the amount bound per individual PDZ domain is twice that bound to PDZ3 alone and four 107 
times that bound to either PDZ1 or PDZ2 alone. 108 
Phosphorylation by CaMKII reduces binding of synGAP to all of the individual PDZ domains and to 109 
to the constructions comprising PDZ12  and PDZ123 (Fig. 1B). The reduction in binding requires the 110 
presence of both Ca2+/CaM and CaMKII in the phosphorylation reaction mixture (Fig. 1C). The fourth bar 111 
of Fig. 1C shows that the reduction in binding is not caused by phosphorylation of PDZ domains on the 112 
column by residual CaMKII. We have shown previously that as many as 10 sites on synGAP are 113 
phosphorylated by CaMKII (Walkup IV et al., 2015). Approximately 5 of these, including site S1123, are 114 
fully phosphorylated after a 0.5 min reaction (Walkup IV et al., 2015 and Fig. 1D). To test whether the 115 
reduction in binding depends primarily on phosphorylation of the rapidly phosphorylated sites or requires 116 
phosphorylation of most of the sites, we tested binding of r-synGAP to PDZ123 after phosphorylation for 117 
various times (Fig. 1E). The reduction in binding is maximal after 0.5 min, indicating that 118 
phosphorylation of the more rapidly phosphorylated sites is sufficient for full reduction of affinity.  119 
Affinity of R-synGAP for the PDZ Domains of PSD-95 Determined by Surface Plasmon Resonance 120 
(SPR)–  The three PDZ domains of PSD-95 are located in the N-terminal half of the protein from residues 121 
61 to 402. The first two PDZ domains are separated by 4 residues and the third is 53 residues downstream 122 
of PDZ2. We determined the affinities of r-synGAP for individual PDZ domains, for PDZ12 and for 123 
PDZ123 by a "competition in solution" assay in which SPR is used to detect the amount of free r-synGAP 124 
in solutions containing a constant amount of r-synGAP and varying amounts of recombinant PDZ 125 
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domains (Nieba et al., 1996; Lazar et al., 2006; Abdiche et al., 2008). To detect the free synGAP, 126 
recombinant PDZ domains are immobilized on the Biacore chip as described under Materials and 127 
Methods. We used the competition method rather than conventional Biacore measurements in which 128 
varying concentrations of r-synGAP are applied to a chip containing immobilized PDZ domains because 129 
concentrations of r-synGAP above ~100 nM produced a large bulk resonance signal caused by high 130 
viscosity that obscured the change in resonance produced by its binding to PDZ domains. The 131 
competition assay eliminates the need to apply high concentrations of synGAP to the chip.  132 
We generated a standard curve in which the maximum resonance responses of a series of 133 
concentrations of synGAP from 0 nM to 50 nM (Fig. 2A, grey traces) were determined and plotted 134 
against synGAP concentration (Fig. 2B, large grey dots). The data were fit with a hyperbolic curve. The 135 
maximum resonance response of a series of mixtures containing 25 nM r-synGAP and increasing 136 
concentrations of PDZ1 from 0 nM to 10 µM were measured, and the concentration of r-synGAP 137 
remaining free to bind to PDZ1 on the chip was then determined from the standard curve (Fig. 2B, small 138 
black dots).  A KD of 140 ± 30 nM (Table 1) was calculated as described under Materials and Methods 139 
(Fig. 2C). We used the same method to measure KDs for PDZ2 and PDZ3 (Fig. 3A and B, respectively) 140 
and KDapps for PDZ12 and PDZ123 (Fig. 3C and D, respectively). The values are summarized in Table 1. 141 
We obtained an additional value of 730 ± 50 nM for the KD of PDZ3 by a conventional Biacore assay, 142 
which is in good agreement with the KD measured by the competition assay. These data show that, under 143 
these conditions, PDZ1 has a higher affinity for synGAP than does PDZ3. 144 
Binding of R-SynGAP Phosphosite Mutants to PDZ123 Affinity Resin–  To determine which phos-145 
phorylation sites are important for the reduction in binding to PDZ domains that we observed in Fig. 1A, 146 
we first examined binding of recombinant mutants of synGAP to PDZ123 affinity resin. Neither mutation 147 
of site S1123 to alanine or aspartate nor double mutation of sites S1093 and S1123 to alanine alters 148 
binding of r-synGAP to PDZ123 before phosphorylation (Fig. 4A). However, each of these mutations 149 
reduces the effect of phosphorylation on binding compared to wild-type after 0.5 min of phosphorylation 150 
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by CaMKII. Mutation of S1123 to alanine had the same effect as double mutation of S1093 and S1123 to 151 
alanines (p = 0.6), indicating that phosphorylation of S1093 has relatively little effect on binding to PDZ 152 
domains; whereas, phosphorylation of S1123 contributes to the reduction of binding to PDZ domains, but 153 
is not sufficient to produce the maximum reduction of binding. In contrast to S1123, mutation of S1283 154 
alone to aspartate reduces the binding of r-synGAP to PDZ123 by ~50% relative to wild-type before 155 
phosphorylation (Fig. 4B), suggesting that phosphorylation of this site alone causes substantial loss of 156 
affinity for PDZ domains. Notably, none of the mutations interfere with the effect of ten min of 157 
phosphorylation (Fig. 4A and B). Taken together, these results mean that phosphorylation of S1283 alone 158 
significantly reduces binding of synGAP to PDZ domains, however maximum loss of binding can be 159 
accomplished only by cumulative phosphorylation over ten min of several sites within the regulatory 160 
disordered domain (See Fig. 1C in Ref. Walkup IV et al., 2015).   161 
Effect of Phosphorylation on Affinity of R-synGAP for PDZ123 Measured by SPR–  We measured the 162 
apparent dissociation constant (KDapp) for binding to PDZ123 of r-synGAP phosphorylated for 10 min by 163 
CaMKII, and of the phosphomimetic mutant r-synGAP S1283D. Phosphorylation for 10 min by CaMKII 164 
increases the KDapp of r-synGAP approximately ten-fold (Fig. 5A, Table 1); whereas mutation of S1283 to 165 
aspartate increases the KDapp approximately four-fold (Fig. 5B, Table 1). Thus, cumulative 166 
phosphorylation of several sites on r-synGAP can reduce affinity for PDZ domains by an order of 167 
magnitude; whereas, addition of a negative charge at S1283 alone can reduce the affinity by a factor of 168 
four.  169 
Ca2+/CaM Binds Directly to R-synGAP–  While studying phosphorylation of r-synGAP by CDK5 170 
(Walkup IV et al., 2015), we found that the presence of Ca2+/CaM in reactions with either CDK5/p35 or 171 
CDK5/p25 doubled the rate and stoichiometry of the phosphorylation (Fig. 6A and B). Inclusion of Ca2+ 172 
or CaM alone in the phosphorylation reactions did not alter the rates or stoichiometry.    173 
We tested whether this effect resulted from binding of Ca2+/CaM to CDK5/p35 (e.g. He et al., 2008) 174 
by comparing the rates of phosphorylation of histone H1, a well-known substrate of CDK5 in the 175 
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presence and absence of Ca2+/CaM (Fig. 6C and D). Phosphorylation of Histone H1 by either CDK5/p35 176 
or CDK5/p25 was unaffected by Ca2+/CaM. This result suggests that Ca2+/CaM binds directly to r-177 
synGAP, causing a substrate-directed enhancement of its phosphorylation.   178 
To further verify that Ca2+/CaM binds directly to r-synGAP, we showed that r-synGAP binds to a 179 
CaM-Sepharose affinity resin in a Ca2+-dependent manner, as would be expected if it binds Ca2+/CaM 180 
specifically and with significant affinity (Fig. 6 -figure supplement 1).  We found that the presence of 181 
Ca2+/CaM alone in a Ras- or Rap-GAP assay has no effect on the GAP activity of synGAP (Fig. 6 -figure 182 
supplement 2). 183 
Affinity of Binding of R-synGAP to Ca2+/CaM–  We measured the affinity of binding of Ca2+/CaM to 184 
r-synGAP by the conventional SPR method on the Biacore as described under Materials and Methods. 185 
CaM was immobilized on a chip, and r-synGAP was applied to it at concentrations from 0 to 75 nM (Fig. 186 
7A). Analysis of the equilibrium phase of association at each concentration (Fig. 7B) yielded a KD of 9 ± 187 
1 nM, indicative of high affinity binding.   188 
To begin to define the location of the high affinity Ca2+/CaM binding site, we compared the affinities 189 
for Ca2+/CaM of r-synGAP and a C-terminal truncated protein, sr-synGAP (residues 103-725; Fig. 1A) by 190 
a bead-binding assay as described under Materials and Methods. We measured the amount of each protein 191 
bound to a fixed amount of CaM-Sepharose after incubation with increasing concentrations (Fig. 7C and 192 
D).  Both r-synGAP (Fig. 7C) and sr-synGAP (Fig. 7D) showed saturable binding to the CaM-Sepharose 193 
resin, and did not bind to control Sepharose beads lacking CaM (data not shown). The data were fit to 194 
hyperbolic curves and the KD’s for binding of r-synGAP and sr-synGAP to Ca2+/CaM were calculated to 195 
be 31 ± 3 nM and 210 ± 30 nM, respectively. Thus, the high affinity site appears to be located in the 196 
regulatory disordered region of r-synGAP, which is missing in sr-synGAP.  The KD‘s determined by the 197 
bead-binding assay (31 ± 3 nM) and Biacore equilibrium binding (9 ± 1 nM) are in the range of those 198 
reported for calcineurin (PP2B) and CaMKII, 1-10 nM (Hubbard and Klee, 1987; Cohen and Klee, 1988) 199 
and 40-80 nM (Miller and Kennedy, 1985; Meyer et al., 1992; Hudmon and Schulman, 2002), 200 
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respectively.  We did not detect any binding when sr-synGAP was injected onto the CaM-substituted 201 
Biacore chip at concentrations from 10-2500 nM.  Thus, the relatively weak binding of sr-synGAP 202 
observed in the bead-binding assay is not reproducible when measured on the Biacore chip. These data 203 
indicate that Ca2+/CaM binds only weakly, if at all, to the N-terminal half of synGAP.  A meta-analysis 204 
algorithm for detecting potential CaM-binding domains (Mruk et al., 2014) predicts two Ca2+/CaM 205 
binding sites in the C-terminal half of synGAP, one from residues 1000-1030 and another in the putative 206 
coiled coil domain from residues 1229-1253. The SPR measurements do not allow us to confirm or to 207 
rule out the presence of two high affinity sites of similar affinity. 208 
Effect of Ca2+/CaM on binding of R-synGAP to PDZ Domains of PSD-95–  We tested whether binding 209 
of Ca2+/CaM alters the binding of r-synGAP to PDZ domains by comparing binding to each affinity resin 210 
in the presence or absence of Ca2+/CaM (Fig. 8A). The presence of Ca2+/CaM during incubation with 211 
resin significantly reduces binding of r-synGAP to PDZ3 and to PDZ123, but not to PDZ1 and/or PDZ2.  212 
Thus, binding of Ca2+/CaM has a more specific, but weaker, effect on binding to the PDZ domains than 213 
does phosphorylation. The effects of phosphorylation and of the presence of Ca2+/CaM during incubation 214 
with resin are not additive (Fig. 8B); that is, the presence of Ca2+/CaM during the incubation with resin 215 
does not further decrease binding of phosphorylated r-synGAP to PDZ123.  216 
SynGAP haploinsufficiency alters the composition of the PSD–  The physiological significance of the 217 
finding that phosphorylation by CaMKII decreases the affinity of synGAP for the PDZ domains of PSD-218 
95 is best considered in the context of the high copy number of synGAP in the PSD. In molar terms, 219 
synGAP is approximately as abundant in the PSD as PSD-95 itself (Chen et al., 1998; Cheng et al., 2006; 220 
Dosemeci et al., 2007; Sheng and Hoogenraad, 2007). Because one synGAP molecule can bind to any one 221 
of the three PDZ domains in each molecule of PSD-95, synGAP could occupy as many as one third of the 222 
PDZ domains of PSD-95 in an average PSD.  Our data suggest that phosphorylation of synGAP by 223 
CaMKII, triggered by activation of NMDARs, would promote dissociation of synGAP from the PDZ 224 
domains, reducing its ability to compete with other proteins for binding.  We therefore propose that 225 
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synGAP normally functions to limit the number of available PDZ domains in the PSD-95 complex, and 226 
that phosphorylation of synGAP by CaMKII partially alleviates the restriction, enabling reconfiguration 227 
of the PSD scaffold. This proposed function is distinct from synGAP’s role as a regulator of Ras and Rap 228 
and could explain its unusually high abundance in the PSD which, until now, has been mysterious (Chen 229 
et al., 1998; Sheng and Hoogenraad, 2007). 230 
SynGAP-/+ mice have been shown to have about half as much synGAP in homogenates from forebrain 231 
as wild-type litter mates. Because binding equilibria are driven not only by the intrinsic affinities of the 232 
binding partners, but also by their concentrations, one prediction of our proposed hypothesis is that 233 
synGAP haploinsufficiency, which reduces the amount of synGAP in the brain by 50% (Vazquez et al., 234 
2004), will cause a significant increase in binding to PSD-95 of other prominent PSD-95 binding proteins, 235 
such as TARPs, LRRTM2s, or neuroligins. Thus, PSDs isolated from synGAP-/+ mice would be predicted 236 
to have less synGAP and more TARPs, LRRTMs, and/or neuroligins bound to PSD-95 than do PSDs 237 
isolated from wild-type mice.  We prepared PSD fractions from the forebrains of  six synGAP-/+ mice and 238 
from six wild-type litter mates and measured the ratios of synGAP, TARPs, LRRTM2, neuroligin-1, and 239 
neuroligin-2 to PSD-95 in the two fractions by quantitative immunoblot as described in Materials and 240 
Methods (Fig 9).  As predicted, the level of synGAP is decreased in relation to PSD-95 by ~ 25% in PSDs 241 
(p = 0.0007) from the synGAP-/+ mice (Fig. 9A).  Furthermore, the ratios of TARPs 2,3,4,ɣ8, and of 242 
LRRTM2 to PSD-95 are significantly increased (Fig. 9B,C; TARP/PSD-95, ~15%, p = 0.017;  243 
LRRTM2/PSD-95, ~16%, p = 0.0035).  This result means that, as predicted, the increase in availability of 244 
PDZ1/2 domains on PSD-95 in the synGAP-/+ mice enhances steady-state binding of TARPs and LRRTMs 245 
to those sites. Interestingly, the ratio of neuroligin-1 to PSD-95 is unchanged in the synGAP-/+ mice (Fig. 246 
9D), suggesting that increased availability of PDZ3 on PSD-95 is not a strong driver of association of 247 
neuroligin-1 with the PSD fraction. However, the ratio of neuroligin-2 to PSD-95 (Fig. 9E) is increased 248 
~10% (p = 0.019). Neuroligin-2 normally associates mostly with inhibitory synapses and mediates their 249 
maturation (Varoqueaux et al., 2004). However, Levinson et al. (2005) reported that over-expression of 250 
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PSD-95 in neurons causes a redistribution of neuroligin-2, increasing the proportion associated with 251 
excitatory synapses. Taken together, these results verify the prediction that a decrease in availability of 252 
synGAP in the PSD scaffold, releases a restriction on binding of TARPs, LRRTMs, and neuroligin-2 to 253 
PSD-95 in vivo and increases their association with the PSD.   254 
DISCUSSION 255 
We have shown that phosphorylation of specific sites on synGAP by CaMKII substantially reduces 256 
the affinity of synGAP’s PDZ ligand for all three of the PDZ domains of PSD-95, and we hypothesize 257 
that this regulation helps to control the composition of the PSD at excitatory synapses. Recently, two 258 
other groups found that movement of synGAP out of the PSD can be triggered in living neurons by 259 
phosphorylation by CaMKII (Yang et al., 2013; Araki et al., 2015).  In the Araki study, the authors 260 
suggested that phosphorylation of synGAP results in “dispersion” of synGAP away from the PSD and 261 
therefore would have the effect of upregulating Ras or Rap near the PSD.  We propose here that a more 262 
important consequence of the decrease in binding of synGAP to the PDZ domains of PSD-95 is 263 
readjustment of the composition of the PSD resulting from increased availability of the PDZ domains of 264 
PSD-95. A cartoon version of this proposed mechanism is shown in Fig. 10.  An average PSD (~360 nm 265 
in diameter) is estimated to contain ~300 molecules of PSD-95 with 900 PDZ domains (Chen et al., 2005; 266 
Sugiyama et al., 2005). Because synGAP is nearly as abundant in PSD-95 complexes as PSD-95 itself 267 
(Chen et al., 1998; Cheng et al., 2006; Dosemeci et al., 2007), synGAP could occupy as many as 300 PDZ 268 
domains in an average synapse. Other proteins that compete for binding to PDZ1 and 2 of PSD-95 include 269 
TARPs and LRRTMs. SynGAP may play an important role in limiting the size and strength of the 270 
synapse by limiting and helping to regulate the available “slots” that can bind AMPAR complexes 271 
(Hayashi et al., 2000; Shi et al., 2001; Opazo et al., 2012).  Our hypothesis predicts that PSDs from mice 272 
with a deletion of one copy of the synGAP gene will contain fewer copies of synGAP and more copies of 273 
other proteins that bind to PSD-95.  Indeed, we have shown here that PSD fractions from synGAP-/+ mice 274 
have ~25% less synGAP per molecule of PSD-95 than those from wild-type mice; and, in contrast, they 275 
peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/058016doi: bioRxiv preprint first posted online Jun. 9, 2016; 
 13 
have significantly more TARP proteins (~15%) , LRRTM2 (~16%), and neuroligin-2 (~9%) per molecule 276 
of PSD-95.  The ratio of neuroligin-1 to PSD-95 is not altered.      277 
Because binding between molecules is driven by both the inherent affinity between the binding 278 
components and by their concentrations, a reduction in binding of synGAP to PDZ domains on PSD-95 279 
produced by phosphorylation by CaMKII, rather than by haploinsufficiency, will also lead to an increase 280 
in the amounts of TARP and LRRTM2, and/or neuroligin-2 in PSDs of wild-type animals.  Acute 281 
phosphorylation of synGAP by CaMKII following activation of NMDARs during induction of LTP could 282 
initiate rearrangement of the composition of PSDs of individual synapses by causing an increase in 283 
equilibrium binding of TARPs, LRRTMs, and their associated AMPARs in the PSD as they diffuse from 284 
perisynaptic locations.  Indeed, the dynamics of movements of synGAP and AMPARs visualized in living 285 
neurons following synaptic stimulation are consistent with this hypothesis. Activation of NMDARs and 286 
CaMKII causes dispersal of synGAP away from the PSD within a few minutes (Yang et al., 2013; Araki et 287 
al., 2015). The same stimuli produce an equally rapid increase in the rate of trapping of AMPARs at 288 
synaptic sites (Opazo et al., 2010; Opazo et al., 2012). Thus, the rates of these two processes observed in 289 
living neurons are compatible with the notion that reduced binding of synGAP to PSD-95 during induction 290 
of LTP opens up binding slots for AMPAR complexes.  291 
Subsequent dephosphorylation of synGAP might be expected to allow synGAP to displace the newly 292 
added TARPs and LRRTMs. Thus, additional processes occurring later in the consolidation of LTP would 293 
be needed to be stabilize the newly added AMPARs in the synapse. These could include degradation of the 294 
phosphorylated synGAP and its replacement by newly synthesized alternatively-spliced isoforms that lack 295 
the C-terminal PDZ binding domain (McMahon et al., 2012). 296 
The restriction by synGAP of binding of neuroligins, in particular neuroligin-2, to PDZ3 of PSD-95 297 
may be more significant during development, during formation of new synapses, or perhaps in later phases 298 
of consolidation of LTP in adults. It is not clear whether a pool of perisynaptic neuroligins exists that could 299 
be readily recruited to new synaptic sites over a few minutes after phosphorylation of synGAP.  In any 300 
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case, the increased steady state amounts of TARPs, LRRTMs, and the small increase in neuroligin-2 that 301 
we observe in excitatory PSDs isolated from forebrain would increase the overall excitatory/inihibitory 302 
(E/I) balance of synapses onto neurons (Levinson and El-Husseini, 2005). 303 
In addition to predicting the altered composition of the PSD in synGAP-/+ mice, our hypothesis 304 
provides a mechanism to explain puzzling results from earlier studies. Neurons cultured from synGAP 305 
deficient mice have been reported by several groups to have a higher average number of AMPARs at their 306 
synapses than wild-type neurons (Kim et al., 2003; Vazquez et al., 2004; Rumbaugh et al., 2006).  The two 307 
PSD-95 binding proteins that are proportionally increased in synGAP heterozygotes, TARPs and 308 
LRRTMs, bind subunits of AMPARs, and are believed to dock them in the synapse by binding to the PDZ 309 
domain “slots” on PSD-95 (Tomita et al., 2005; de Wit et al., 2009).  Our data indicates that the increase in 310 
AMPARs in synGAP+/- mice is a direct result of increased binding of TARPs and LRRTM to PDZ 311 
domains that are made available by the reduced amount of synGAP.   312 
A second example is the observation that absence of synGAP in hippocampal neurons cultured from 313 
synGAP deficient mice leads to accelerated maturation of spines, including early movement of PSD-95 314 
into spine heads, and ultimately larger clusters of PSD-95 in individual synapses compared to wild-type 315 
neurons (Vazquez et al., 2004). We found that expression of wild-type-synGAP in the mutant neurons 316 
rescued all of these phenotypes; however, expression of synGAP with a deletion of the five residue PDZ 317 
ligand (ΔSXV) failed to rescue any of the effects of synGAP deficiency on accelerated maturation of 318 
spines. In fact, expression of synGAP-ΔSXV actually further increased the size of clusters of PSD-95 in 319 
spines compared to wild-type neurons. This failure to rescue the phenotypes was not a result of 320 
mislocalization of synGAP; synGAP-ΔSXV localized normally to developing spine heads. Instead, the data 321 
are consistent with the idea that synGAP normally competes with several proteins for binding to the PDZ 322 
domains of PSD-95, and thus limits the size of clusters of PSD-95 and its associated proteins, as well as 323 
their movement into spine heads (Vazquez et al., 2004). 324 
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We note that the reduction in affinity of synGAP for PDZ domains of PSD-95 after phosphorylation by 325 
CaMKII is apparently not sufficient for complete dispersal of synGAP away from the PSD, although it is 326 
likely necessary. We found that synGAP-ΔSXV, which cannot bind to PDZ domains, still localizes to 327 
synaptic spines (Vazquez et al., 2004).  Furthermore, Barnett et al. (Barnett et al., 2006) showed that, in 328 
developing S1 rodent cortex, isoforms of synGAP that do not contain the PDZ ligand are, nevertheless, 329 
bound to the PSD. These data mean that reduction of affinity of synGAP for PDZ domains may be 330 
sufficient to decrease its ability to compete for binding slots on PSD-95; however, complete detachment of 331 
synGAP from the PSD in vivo appears to require additional events. 332 
Others have proposed that, in general, PDZ domains act as flexible protein interaction points that can 333 
be modified to support changes in cytoplasmic organization (Kurakin et al., 2007). Complexes formed by 334 
PDZ domain interactions are examples of linked equilibria, the stable configurations of which are 335 
determined by the concentrations of each component and by their affinities for the relevant PDZ domains. 336 
Evidence has indicated that PSD-95 protein complexes exist in dynamic equilibrium permitting continual 337 
turnover and potential rearrangement of their composition (Sturgill et al., 2009; Schapitz et al., 2010).  338 
SynGAP is an abundant protein in the PSD with a relatively high affinity for all three of the PDZ domains 339 
of PSD-95; therefore, it will occupy a relatively large number of its PDZ domains at equilibrium. However, 340 
when synGAP’s affinities for the PDZ domains are reduced after phosphorylation, other components will 341 
begin to compete more effectively for binding and the composition of the PSD-95 complex will shift to a 342 
new equilibrium.  343 
The functional significance of our finding that synGAP contains a high affinity binding site for 344 
Ca2+/CaM is less clear. We have shown that binding of Ca2+/CaM alters the conformation of the carboxyl 345 
terminal regulatory domain of synGAP allowing CDK5 to phosphorylate additional sites; the binding also 346 
reduces the affinity of synGAP for PDZ3 by ~25%. However, the consequences of these two effects for 347 
synaptic function are not known.  However, once again, the high copy number of synGAP in the PSD may 348 
provide a clue.  The biochemical events initiated by Ca2+ flux through NMDARs that lead to changes in 349 
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synaptic strength  (Sjostrom and Nelson, 2002) are initiated by formation of transient and limiting 350 
concentrations of Ca2+/CaM in the spine (Markram et al., 1998; Pepke et al., 2010). Approximately ten 351 
regulatory enzymes compete for binding of, and activation by, this Ca2+/CaM (Kennedy, 2013). Because of 352 
the abundance of synGAP in the PSD, the high affinity binding site for Ca2+/CaM on synGAP will compete 353 
effectively for the newly formed Ca2+/CaM and may act as a Ca2+/CaM buffer. 354 
Haploinsufficiency of synGAP in humans is the cause of ~5% of cases of nonsyndromic cognitive 355 
disability and ~9% of such cases with co-morbid Autism Spectrum Disorder or Epilepsy (Berryer et al., 356 
2013). The reduced amount of synGAP and resulting decrease in its ability to compete for PDZ domains 357 
are almost certainly significant factors in the pathology of these disorders, perhaps more significant than 358 
the reduction in synaptic Ras/Rap GAP activity.  The increase in E/I balance in the forebrain predicted by 359 
our results could produce the symptoms of cognitive disability, ASD, and/or epilepsy observed in humans 360 
with synGAP haploinsufficiency.  It would be worth considering whether pharmaceutical agents could be 361 
designed that would bind to PDZ domains of PSD-95 and compensate for the reduced level of synGAP. 362 
Materials and Methods 363 
Cloning, Expression and Purification of R-synGAP– Soluble, recombinant synGAP (r-synGAP), 364 
comprising residues 103-1293 in synGAP A1-α1 (118-1308 in synGAP A2-α1), or sr-synGAP, 365 
comprising residues 103-725 in synGAP A1-α1 (118-740 in synGAP A2-α1), was purified from E. coli as 366 
previously described (Walkup IV et al., 2015). The isoform names and residue numbering are taken from 367 
ref. (Walkup IV et al., 2015). Henceforth, except where indicated, we use residue numbering 368 
corresponding to synGAP A1-α1.    369 
Briefly, a pET-47b(+) plasmid (EMD Millipore, Billerica, MA, catalog no. 71461) containing 370 
synGAP cDNA (AF048976) fused to an N-terminal 6x Histidine Tag and a PreScission Protease cleavage 371 
site was transformed into the Rosetta2(DE3) E. coli strain (EMD Millipore, catalog no. 71397) for protein 372 
expression. Bacterial pellets were harvested by centrifugation and lysed by microfluidization in a ML-110 373 
microfluidizer (Microfluidics Corp., Westwood, MA). Soluble synGAP was purified on Talon Metal 374 
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Affinity Resin (Clontech, Mountain View, CA, catalog no. 635503), and concentrated by ultrafiltration 375 
through a 150 kDa cutoff-filter (Thermo Scientific, Waltham, MA, catalog no. 89923) for r-synGAP or 9 376 
kDa cutoff-filter (Thermo Scientific, catalog no. 89885A) for sr-synGAP. Concentrated samples of r-377 
synGAP were exchanged into storage buffer (20 mM Tris, pH 7.0; 500 mM NaCl, 10 mM TCEP, 5 mM 378 
MgCl2, 1 mM PMSF, 0.2% Tergitol Type NP-40, and Complete EDTA-free protease inhibitor) by 379 
ultrafiltration, flash-frozen in liquid nitrogen, and stored at -80° C. Sr-synGAP was further purified on a 380 
size exclusion column prior to storage (Walkup IV et al., 2015).   381 
Cloning, Expression and Purification of PDZ Domains from PSD-95–  Soluble recombinant PDZ 382 
domains, comprising residues 61-151 (PDZ1),155-249 (PDZ2), 302-402 (PDZ3), 61-249 (PDZ12), and 383 
61-403 (PDZ123) from murine PSD-95 (Q62108) were purified from E. coli as previously described 384 
(Walkup IV and Kennedy, 2014, 2015) with the modifications below.    385 
Briefly, pJExpress414 plasmids (DNA2.0, Menlo Park, CA, catalog no. pJ414) containing codon 386 
optimized PDZ domains were transformed into the BL21(DE3) E. coli strain (EMD Millipore, catalog no. 387 
70235-3) for protein expression. Single colonies of BL21(DE3) cells harboring pJExpress414 plasmids 388 
were grown overnight at 37 °C in lysogeny broth (LB) (Teknova, Hollister, CA, catalog no. L9110) 389 
supplemented with 100 µg/ml carbenicillin. Overnight cultures were diluted 1:500 into LB medium and 390 
grown at 37 °C until cultures reached an O.D.600 of 1.0. IPTG was added to a final concentration of 0.2 391 
mM, and cultures were grown for an additional 4.5 hours at 37 °C. Bacterial pellets were harvested by 392 
centrifugation and lysed using non-ionic detergent (BugBuster) and ReadyLyse. Soluble PDZ1, PDZ2 393 
and PDZ12 domains were purified on GluN2B peptide (GAGSSIESDV) PDZ Ligand Affinity Resin 394 
(Walkup IV and Kennedy, 2014) by eluting with 400 µg/ml SIETEV peptide. PDZ3 and PDZ123 were 395 
purified on CRIPT peptide (GAGNYKQTSV) PDZ Ligand Affinity Resin (Walkup IV and Kennedy, 396 
2014) by eluting with 400 µg/ml YKQTSV peptide. PDZ domains were concentrated by ultrafiltration 397 
through a 3 kDa Amicon Ultracentrifugal Filter Unit (EMD Millipore, catalog no. UFC 900396). The 398 
PDZ peptide ligands were removed from PDZ domains by dialysis into storage buffer (50 mM HEPES, 399 
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pH 7.5; 100 mM NaCl, 5 mM TCEP, 1 mM PMSF, and Complete EDTA-free protease inhibitor). 400 
Purified PDZ domains (>99% pure; 45-610 µM; Fig. 1 figure supplement 1) were flash-frozen in liquid 401 
nitrogen, and stored at -80° C. 402 
SDS-PAGE, Immunoblotting and Assessment of Protein Purity and Yield– We used SDS-PAGE to 403 
determine purity of proteins and to quantify binding to PDZ domain resin. Protein samples were diluted 404 
1:3 into 3x Laemmli buffer (100 mM Tris HCl, pH 6.8; 2.1% SDS, 26% glycerol, 7.5% β-405 
mercaptoethanol, and 0.01% bromophenol blue) and heated to 95° C for 3 minutes before fractionation on 406 
8% SDS-PAGE gels at 165 V in 25 mM Tris base, 192 mM glycine, 0.1% SDS. Proteins were stained 407 
with Gel Code Blue (Thermo Scientific, catalog no. 24592), imaged on a LI-COR Odyssey Classic 408 
Infrared Imaging System (LI-COR Biosciences, Lincoln, NE) at 700 nm, and quantified with LI-COR 409 
Image Studio Software (v4.0.21) against standard curves of BSA (catalog no. A7517-1VL) and lysozyme 410 
(catalog no. L4631-1VL) purchased from Sigma-Aldrich, St. Louis, MO. The protein standards were 411 
loaded onto each gel in lanes adjacent to the protein samples. Molecular weights of stained proteins were 412 
verified by comparison to Precision Plus Protein All Blue Standards (BioRad, Hercules, CA, catalog no. 413 
161-0373).  414 
For immunoblotting, proteins fractionated by SDS-PAGE were electrically transferred to low 415 
fluorescence PVDF membranes (Thermo Scientific, catalog no. 22860) in 25 mM Tris, 200 mM glycine, 416 
and 20% methanol. Membranes were washed with 50 mM Tris-HCl, pH 7.6; 150 mM NaCl (TBS) 417 
followed by blocking with Odyssey Blocking Buffer (LI-COR Biosciences, catalog no. 927-50000). 418 
Membranes were washed in TBS supplemented with 0.1% Tween 20 (TBS-T) before incubation in 419 
Odyssey Blocking Buffer containing 1:1000 diluted rabbit anti-synGAP (Pierce, Rockford, IL, catalog no. 420 
PA1-046) or 1:1500 BSA-free anti-TetraHis (Qiagen, Germany, catalog no. 34670). Bound antibodies 421 
were detected with 1:10,000 goat anti-mouse Alexa-Fluor 680 (Life Technologies, Carlsbad, CA, catalog 422 
no. A-21057) or 1:10,000 goat anti-rabbit Alexa-Fluor 680 (Life Technologies, catalog no. A-21109) 423 
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visualized with a LI-COR Odyssey Classic Infrared Imaging System and quantified with LI-COR Image 424 
Studio Software. 425 
Synthesis of PDZ Domain Affinity Resins– PDZ domain affinity resins (PDZ1, residues 61-151; 426 
PDZ2, residues 155-249; PDZ3, residues 302-402; PDZ12, residues 61-249; PDZ123, residues 61-402 427 
from murine PSD-95) were prepared by the HaloTag-HaloLink method as previously described (Walkup 428 
IV and Kennedy, 2014, 2015). Briefly, bacterial cell pellets containing PDZ domain-HaloTag fusion 429 
proteins were resuspended in 10 ml/g of Purification Buffer, and lysed by three passes through a ML-110 430 
microfluidizer. The lysate was clarified by centrifugation, added to HaloLink resin (Promega, Madison, 431 
WI, catalog no. G1915), and mixed with continuous agitation for 1.5 hours at 4° C on an end-over-end 432 
mixer. Unbound protein was separated from the resin by centrifugation and the PDZ-HaloTag-HaloLink 433 
resin was resuspended, transferred to a column, and allowed to settle. The resin was extensively washed 434 
and then stored at 4° C in a buffer supplemented with 0.05% NaN3. The resin was used or discarded 435 
within 1 week of preparation. The densities of PDZ domains on the resin varied from 50 to 100 pmol of 436 
PDZ123 domain and from 200 to 500 pmol of PDZ1, PDZ2, PDZ3, or PDZ12 domains per µl resin.  437 
Assay for Binding of R-synGAP to PDZ domain Resin– Phosphorylated or non-phosphorylated 438 
synGAP (500 nM, 200 µl) was mixed with 20 µl of affinity resin containing PDZ1, PDZ2, PDZ3, PDZ12, 439 
or PDZ123 domains, pre-equilibrated with Binding/Wash Buffer (25 mM Tris, pH 7.0; 150 mM NaCl, 1 440 
mM MgCl2, 0.5 mM TCEP, 0.2% Tergitol, 0.5 mM EDTA) in a cellulose acetate spin cup (Pierce, catalog 441 
no. 69702) for 60 min on an end-over-end mixer. In some experiments, 2.5 µM CaM and 0.5 mM CaCl2 442 
were included to test the effect of binding of Ca2+/CaM to synGAP on synGAP’s affinity for PDZ 443 
domains. After the incubation, the resin in the spin cup was centrifuged for 2 min at 1,500 x g to remove 444 
unbound protein, and the resin was washed 4 times with 200 µl of Binding/Wash Buffer. To elute bound 445 
protein, 100 µl of 1x Laemmli Buffer was added and the resin was incubated for 5 min at room 446 
temperature. The eluted protein was collected by centrifugation at 6,000 x g for 2 min, fractionated by 447 
SDS-PAGE, stained with Gel Code Blue, and quantified on a LI-COR Classic as described above. 448 
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Integrated intensities reflecting the amount of bound synGAP were determined with LI-COR software 449 
and plotted with Prism (v6.0d, GraphPad Software, La Jolla CA).   450 
Phosphorylation of R-synGAP by CaMKII for PDZ Binding Assays– Phosphorylation of r-synGAP by 451 
CaMKII was carried out immediately prior to PDZ binding assays, as previously described (Walkup IV et 452 
al., 2015). Reaction mixtures contained 50 mM Tris-HCl, pH 8.0; 10 mM MgCl2, 0 or 0.7 mM CaCl2 , 0.4 453 
mM EGTA, 30 µM ATP, 0 or 3.38 µM CaM, 10 mM DTT, 725 nM r-synGAP, and 0 or 10 nM CaMKII. 454 
Samples were quenched by addition of 1/3 volume of 50 mM Tris, pH 8.0; 0.4 M NaCl, 10 mM MgCl2, 455 
0.8% tergitol (Type NP-40), 6 µM autocamtide-2 related inhibitory peptide (Genscript, China), 40 mM 456 
EGTA at the indicated times. When we planned to add Ca2+/CaM during the subsequent incubation with 457 
resin, the EGTA was omitted. Samples were stored on ice until their use in PDZ domain binding assays. 458 
Stoichiometry and Rate of Phosphorylation of R-synGAP and Histone H1 by CaMKII and/or CDK5–  459 
Phosphorylation of 725 nM synGAP by 10 nM CaMKII was carried out as previously described (Walkup 460 
IV et al., 2015) in reaction mixtures containing 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 0 or 0.7 mM 461 
CaCl2, 0.4 mM EGTA, 500 µM [γ-32P]-ATP (375 cpm/pmol) (6000 Ci/mmol, Perkin Elmer, Waltham, 462 
MA, catalog no. BLU002Z/NEG002Z), 0 or 3.4 µM CaM, 10 mM DTT.  Phosphorylation of 286 nM r-463 
synGAP and 4.3 µM Histone H1 (New England Biolabs, Ipswich, MA, catalog no. M2501S), by 464 
CDK5/p35 (EMD Millipore, catalog no. 14-477M) or CDK5/p25 (EMD Millipore, catalog no. 14-516) 465 
was carried out in the same reaction mixture containing 110 nM CDK5/p35 or CDK5/p25 but no 466 
CaMKII. After fractionation by SDS-PAGE, phosphorylated proteins were quantified with a Typhoon LA 467 
9000 phosphorimager (GE Healthcare Life Sciences, Pittsburg, PA) as previously described (Walkup IV 468 
et al., 2015). Relative densities were converted to pmol phosphate by comparison to densities of standard 469 
amounts of [γ-32P]-ATP. The stoichiometry of phosphorylation was calculated by dividing mol of 470 
incorporated phosphate by mol of synGAP loaded per lane. 471 
Measurement of Affinity of R-synGAP for PDZ Domains by Surface Plasmon Resonance (SPR)–   We 472 
used a “competition in solution” method (also called “affinity in solution”) (Nieba et al., 1996; Lazar et 473 
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al., 2006; Abdiche et al., 2008) to measure the affinity of r-synGAP for PDZ domains. In this method, 474 
PDZ domains are immobilized on the chip surface and used to capture and measure the concentration of 475 
free r-synGAP in pre-equilibrated mixtures of a constant amount of r-synGAP with varying amounts of 476 
soluble recombinant PDZ domains. Experiments were performed on a Biacore T200 (GE Healthcare Life 477 
Sciences). Purified PDZ domains (PDZ1, PDZ2, PDZ3, PDZ12, PDZ123 from PSD-95) were coupled to 478 
Series S CM5 Sensor Chips (GE Healthcare Life Sciences, catalog no. BR-1005-30) by the amine 479 
coupling protocol specified in the Biacore T200 Control Software with reagents purchased from GE 480 
Healthcare Life Sciences. Sensor surfaces were activated by applying a 1:1 mixture of 50 mM N-481 
hydroxysuccinimide (NHS) : 200 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 482 
(EDC) provided in the Biacore Amine Coupling Kit (GE Healthcare Life Sciences, catalog no. BR-1000-483 
50) dissolved in HBS-N running buffer (degassed 0.01 M HEPES pH 7.4, 0.15 M NaCl) (GE Healthcare 484 
Life Sciences, catalog no. BR-1006-70). PDZ domains  were diluted to 0.1-5 µM in Biacore Sodium 485 
Acetate Buffer [10 mM sodium acetate, pH 4.0 (GE Healthcare Life Sciences, catalog no. BR-1003-49) 486 
for PDZ1 and PDZ3; pH 4.5 for PDZ2; pH 5 for PDZ12 and PDZ123]. PDZ domains were injected into 487 
flow cells 2 and 4 until 200 to 400 RU (resonance units) of PDZ domain were immobilized. Flow cells 1 488 
and 3 were left blank to be used as reference surfaces. Ethanolamine (1 M, pH 8.5) was injected for 7 min 489 
at 10 µl/min to block remaining active sites on all four flow cells.  490 
A calibration curve was prepared by applying samples of 0 to 50 nM r-synGAP prepared by two-fold 491 
serial dilution of 50 nM r-synGAP into 1x HBS-EP+ buffer (degassed 0.01 M HEPES, pH 7.4; 0.15 M 492 
NaCl, 3 mM EDTA, 0.05% v/v Surfactant P20; GE Healthcare Life Sciences, catalog no. BR-1006-69) to 493 
the chip and recording the maximum RU for each concentration. Samples for calibration were incubated 494 
for 2 hours at room temperature before randomized injection onto the chip surface at 25° C at 10 µl/min 495 
for 200 sec over all four flow cells. Between each sample injection, the chip was regenerated by injecting 496 
1 M MgCl2 at 100 µl/min for 60 sec, waiting 180 sec for the baseline to stabilize, then injecting a second 497 
pulse of MgCl2 solution, waiting 300 sec for the baseline to stabilize, and finally executing a “carry over 498 
control injection” in which HBS-EP+ buffer is flowed over the chip surface at 40 µl/min for 30 sec. 499 
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Mixtures of r-synGAP and PDZ domains were prepared by 1:1 dilution of 50 nM r-synGAP with two-500 
fold serial dilutions of PDZ domains (0-20 µM PDZ1, PDZ2, PDZ3, PDZ12 or 0-160 µM PDZ123) in 501 
HBS-EP+ buffer to produce mixtures containing 25 nM r-synGAP and 0-10 µM PDZ1, PDZ2, PDZ3, 502 
PDZ12 or 0-80 µM PDZ123. For each mixture of r-synGAP and PDZ domain, the different 503 
concentrations were injected randomly and a series of sensorgrams were recorded as described for the 504 
calibration curve. 505 
Sensorgrams were processed with Biacore T200 Evaluation Software, (ver. 3.0, GE Healthcare Life 506 
Sciences). The y-axes were zeroed at the baseline for each cycle and x-axes were aligned at the injection 507 
start. Bulk refractive index changes and systematic deviations in sensorgrams were removed by 508 
subtracting the responses in reference flow cells corresponding to the sample flow cells (e.g. 2-1, 4-3). 509 
The averaged sensorgrams for 0 nM r-synGAP were then subtracted from sensorgrams for all other 510 
concentrations. The concentrations of free r-synGAP in each mixture with PDZ domains was determined 511 
from the calibration curve, exported into Prism, and plotted against the log of PDZ domain concentration. 512 
The curve was fit to the equation:  513 
 
synGAPfree =
(synGAPtot − PDZtot − KD)
2
±
(PDZtot + synGAPtot + KD )
2
4
− (PDZtot × synGAPtot )   514 
Equilibrium dissociation constants (KD) for binding to PDZ1, PDZ2, and PDZ3, and apparent 515 
equilibium dissociation constants for binding to PDZ12 and PDZ123 (KDapp) were determined from the 516 
best fit curves as described in the Biacore T200 Software Handbook (p. 210).  517 
Binding of R-synGAP to CaM-Sepharose– Rosetta2(DE3) cells containing sr-synGAP or r-synGAP 518 
were lysed in Lysis buffer as described in Walkup et al. (2015) except that the buffer contained 200 mM 519 
NaCl, 0 or 5 mM CaCl2, and 0 or 10 mM EGTA. The resuspended cells were lysed by sonication with a 520 
Digital Sonifier 450 Cell Disruptor (Branson, Danbury, CT) for two passes at 90 seconds/pass (15% 521 
power, 1.0 second on, 1.5 seconds off), and insoluble material was removed by centrifugation at 16,000 × 522 
g for 40 min at 4° C. Clarified cell lysate (1.7 ml) containing sr-synGAP or r-synGAP (~6 mg/ml total 523 
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protein) was incubated with end-over-end mixing for 60 min with 0.3 ml CaM-Sepharose 4B (GE 524 
Healthcare Life Sciences, catalog no. 17-0529-01) or control Sepharose 4B (GE Healthcare Life Sciences, 525 
catalog no. 17-0120-01). The resin was pipetted into a BioSpin column (Bio-Rad, catalog no. 732-6008) 526 
and washed with 12 ml (40 column volumes) of Lysis/Wash Buffer. Bound protein was eluted with 1.2 527 
ml (4 column volumes) of Lysis/Wash Buffer containing 100 mM EGTA. Eluted proteins (30 µl aliquot) 528 
were resolved by SDS-PAGE and transferred to a PVDF membrane which was probed with anti-synGAP 529 
or BSA-free anti-TetraHis as described above. 530 
Measurement of Affinity of CaM for R-synGAP by SPR– Direct binding of r-synGAP to Ca2+/CaM 531 
immobilized on a chip was assayed on a Biacore T200 with a Series S Sensor Chip CM5. CaM (Enzo, 532 
Farmingdale, NY, catalog no. BML-SE325-0001) was coupled to the chip by the amine coupling protocol 533 
specified in the Biacore T200 Control Software, as described above. Purified, lyophilized CaM (250 µg) 534 
was resuspended in water and exchanged into Biacore Sodium Acetate, pH 4.0 Buffer (10 mM sodium 535 
acetate, pH 4.0) with an Amicon Ultra-0.5 ml centrifugal filter with a 3 kDa molecular weight cutoff 536 
(EMD Millipore, catalog no. UFC500396). CaM was further diluted to 0.5 nM in 10 mM Sodium 537 
Acetate, pH 4.0, and injected into flow cells 2 and 4 until 50 RU of CaM were immobilized (~7 min at a 538 
flow rate of 10 µl/min). Flow cells 1 and 3 were left blank to be used as reference surfaces. Ethanolamine 539 
(1 M, pH 8.5) was injected for 7 min at 10 µl/min to block remaining active sites on all four flow cells. R-540 
synGAP (0 nM to 75 nM) in 1x HBS-EP+ running buffer supplemented with 10 mM CaCl2, was injected 541 
in triplicate at 25° C at 100 µl/min for 75 sec over all four flow cells. Different concentrations of r-542 
synGAP were applied in randomized order. After injection ended, dissociation was monitored in each 543 
flow cell for 500 sec. Regeneration of the sensor chip was performed by injecting 50 mM NaOH (GE 544 
Healthcare Life Sciences, catalog no. BR-1003-58) at 100 µl/min for 30 sec, waiting 180 sec for the 545 
baseline to stabilize, then injecting a second pulse of NaOH, waiting 240 second for the baseline to 546 
stabilize, and finally executing a “carry over control injection.” Sensorgrams were processed using the 547 
Biacore T200 Evaluation Software, version 3.0, as described above. Resonance units of bound synGAP at 548 
equilibrium were exported into Prism and plotted against the concentrations of r-synGAP. The data were 549 
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fit globally to a hyperbolic curve by nonlinear regression to determine equilibrium dissociation constants 550 
(KD). 551 
Determination of Affinity of Ca2+/CaM for Sr- and R-synGAP by Equilibrium Binding to CaM-552 
Sepharose–  Purified sr-synGAP and r-synGAP were diluted to 1 to 500 nM in Binding/Wash Buffer (50 553 
mM Tris, pH 7.5; 200 mM NaCl, 5 mM TCEP, 2 mM CaCl2).  Aliquots of diluted synGAP (300 µl) were 554 
incubated with end-over-end mixing for 60 minutes with 50 µl of CaM-Sepharose 4B in a screw cap spin 555 
column (Thermo Scientific, catalog no. 69705). Concentrations of sr- and r-synGAP were 20-3,000 fold 556 
below the ligand binding capacity of the CaM-Sepharose resin. Unbound protein was removed by 557 
centrifugation at 4,000 x g for 30 seconds. Beads were washed in Binding/Wash Buffer (250 µl, 5 558 
volumes), and bound protein was eluted with 50 µl of 1x Laemmli buffer with 10% β-mercaptoethanol. 559 
Eluted proteins were fractionated by SDS-PAGE and transferred to a PVDF membrane as described 560 
above. Blots were probed with 1:1000 anti-synGAP or 1:1500 BSA-free anti-TetraHis anti-bodies and 561 
quantified on a LI-COR Classic as described above. Integrated intensities reflecting the amount of bound 562 
synGAP were determined with LI-COR software and plotted against the corresponding concentrations of 563 
synGAP with Prism software. The data were fit to a hyperbolic curve by nonlinear regression to 564 
determine the dissociation constant (KD).  565 
Preparation of PSD fractions–   PSD fractions were prepared as previously described (Cho et al., 566 
1992) from six wild-type and six SynGAP-/+ mouse litter mates matched by age (7-12 weeks), and sex 567 
(wild-type, 1 female, 5 males; synGAP-/+, 2 female, 4 male). The mice were killed by cervical dislocation 568 
and forebrains were dissected and rinsed in Buffer A (0.32 M sucrose, 1 mM NaHCO3, 1 mM MgCl2, 0.5 569 
mM CaCl2, 0.1 mM PMSF, 1 mg/l leupeptin). Forebrains from each set of six mice were pooled and 570 
homogenized with 12 up and down strokes at 900 rpm in 14 ml Buffer A. Homogenates were diluted to 571 
35 ml in Buffer A and centrifuged at 1400 × g for 10 min. The pellet was resuspended in 35 ml Buffer A, 572 
homogenized (3 strokes), and centrifuged at 710 g for 10 min. Supernatants from the two centrifugations 573 
were combined and centrifuged at 13,800 g for 10 min. The pellet was resuspended in 8 ml of Buffer B 574 
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(0.32 M sucrose, 1 mM NaH2CO3), homogenized with 6 strokes and layered onto a sucrose gradient (10 575 
ml each of 0.85 M, 1.0 M, and 1.2 M sucrose in 1 mM NaH2CO3 buffer). The gradient was centrifuged 576 
for 2 hours at 82,500 g in a swinging bucket rotor. The synaptosome-enriched layer at the interface of 1.0 577 
and 1.2 M sucrose was collected, diluted to 15 ml with Solution B and added to an equal volume of 578 
Buffer B containing 1% Triton. The mixture was stirred for 15 min at 4°C and centrifuged for 45 min at 579 
36,800 g. The pellet containing the PSD-enriched, Triton-insoluble fraction was resuspended in 800-1000 580 
µl of 40 mM Tris pH 8 with a 21 gauge needle and 1 ml syringe, and further solubilized by hand in a 581 
teflon glass homogenizer. Samples were aliquoted and stored at -80° C. 582 
Quantification of Proteins in PSD Fractions–  PSD samples contained six pooled biological replicates  583 
of each of the two genotypes.  Equal amounts of protein from each PSD sample (5-15 µg) were dissolved 584 
in SDS-PAGE sample buffer (33 mM Tris HCl, pH 6.8; 0.7% SDS, 10% glycerol, 2.5% β-585 
mercaptoethanol, and 0.003% bromophenol blue), heated at 90 °C for 5 min, fractionated on 586 
polyacrylamide gels (8% or 10%), and electrically transferred to PVDF membranes in pre-cooled 25 mM 587 
Tris, 150 mM glycine, 2% methanol at 250V for 2.5 hours at 4˚C. Membranes were blocked with Odyssey 588 
blocking buffer (LI-COR Biosciences) and then incubated in a primary antibody solution of 5% BSA in 589 
TBS-T overnight at 4˚C, as described above. Primary antibodies included mouse-anti-PSD-95 590 
(ThermoFisher, catalog no. MA1-046 [clone 7E3-1B8], dilution 1:10,000), rabbit-anti-SynGAP (Pierce, 591 
catalog no. PA1-046, dilution 1:3500), rabbit-anti-TARP (ɣ-2,3,4, and 8; EMD Millipore, catalog no. 592 
Ab9876; dilution 1:300), rabbit-anti-LRRTM2 (Pierce, catalog no. PA521097; dilution 1:3000), mouse-593 
anti-neuroligin-1 (Sigma, catalog no. sab5201464; dilution 1:250), and rabbit-anti-neuroligin-2 (Synaptic 594 
Systems, Germany, catalog no. 129202; dilution 1:1000). The membranes were then washed 3-times in 595 
TBS-T.  The membrane was incubated with secondary antibodies (Alexa Fluor 680-goat-anti-mouse IgG 596 
(Life Technologies, catalog no. A21057; 1:10,000) or IRDye800-goat-anti-rabbit IgG (Rockland, 597 
Limerick, PA, catalog no. 611-132-122; 1:10,000) for 45 minutes at room temperature in 5% nonfat milk 598 
in TBS-T, then washed 3 times in TBS-T, then twice in TBS prior to scanning. For most experiments, each 599 
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blot contained 6 duplicate samples of PSD fractions from wild-type and the same number from synGAP-/+ 600 
mice.  Each blot was incubated with a mixture of two primary antibodies; mouse-anti-PSD-95 and the 601 
antibody against neuroligin-1, neuroligin-2, TARPs, LRRTM2, or synGAP.  Then the blots were incubated 602 
with a mixture of the appropriate secondary antibodies.  For measurement of neuroligin-1, both PSD-95 603 
and neuroligin-1 were detected by the same goat anti-mouse secondary; the bands were physically 604 
separated on the gel and were quantified independently.  Bound antibodies were visualized in the 605 
appropriate fluorescent channels with an Odyssey Classic Infared Imaging System (LI-COR Biosciences, 606 
Lincoln, Nebraska).   607 
Before running samples for quantification, we determined empirically the amount of PSD sample that 608 
would result in signals for each protein that were strong enough for measurement and not saturated.  To 609 
quantify the densities of the bands, each visual image was first set to high brightness in order to capture the 610 
boundaries of the signals for each band. The images were then used as a template in LI-COR software to 611 
draw rectangular regions of interest around protein bands, and around identically sized background regions 612 
in the same lane. Background densities were subtracted from each protein signal. Two blots were excluded 613 
because background density formed a gradient across the gel resulting in more variation in measurement 614 
for one of the genotypes. The Digital data read by the LI-COR software is unchanged by the visualization 615 
settings and is linear over several orders of magnitude. For each lane, the ratio of the integrated density of 616 
each of the five proteins to the integrated density of PSD-95 was calculated. For three gels, one outlier 617 
measurement (defined as greater than 2 times the standard deviation of the mean) was excluded from the 618 
calculation.  A few bands were also excluded from measurement when a bubble during the transfer 619 
distorted and blurred the signal.  The mean and standard error of the mean (S.E) of the ratios were 620 
determined for wild-type and synGAP-/+ PSD fractions.  The means were compared by t-tests performed 621 
with Prism software as indicated in the legend of Fig. 9.  For four of the proteins, the number of 622 
measurements was sufficient to determine a significant difference between wild-type and synGAP-/+.  In the 623 
case of neuroligin-1, the means were identical after 24 individual measurements of each sample. 624 
 625 
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FIGURE 1. Phosphorylation by CaMKII regulates association of r-synGAP with PDZ domains of PSD-4 
95.  A, Domain diagrams of synGAP (Walkup IV et al., 2015) and PSD-95 (Cho et al., 1992).  The 5 
boundaries of r-synGAP and sr-synGAP are indicated, as are the locations of the major sites 6 
phosphorylated by CaMKII, most of which are in the “disordered domain.” Numbering is based on rat 7 
isoform synGAP A1-α1. The 5 residue PDZ ligand is located at the C-terminus. The five major domains 8 
of PSD-95, including the approximate relationships of its three N-terminal PDZ domains are indicated.  9 
B, Association of r-synGAP with PDZ domains of PSD-95 before and after phosphorylation by CaMKII. 10 
R-synGAP was incubated in a phosphorylation mix for 10 min with either 0 CaMKII and 0 Ca2+/CaM 11 
(control) or 10 nM CaMKII and 0.7 mM CaCl2 /3.4 µM CaM (+ CaMKII) before binding to PDZ domain 12 
resins for 60 min at 25° C, as described under Materials and Methods. For comparison of binding of 13 
control to phosphorylated synGAP: PDZ1, p <0.0001; PDZ2, p = 0.0001; PDZ3, p <0.0001; PDZ12, p = 14 
0.002; PDZ123, p <0.0001 C, Both Ca2+/CaM and CaMKII are required in the phosphorylation reaction to 15 
reduce binding of synGAP to PDZ123 resin.  R-synGAP was incubated in the phosphorylation reaction 16 
without Ca2+/CaM or CaMKII (Control), with CaMKII alone, or with both before binding to PDZ resin. 17 
For comparison of Control to phosphorylation: + CaMKII, p = 0.2; +Ca2+/CaM, +CaMKII, p <0.0001. 18 
The final bar shows that phosphorylation of the PDZ123 domain resin itself doesn’t alter binding of r-19 
synGAP.  PDZ123 domain affinity resin was phosphorylated for 60 min in the presence of CaMKII and 20 
0.7 mM CaCl2/3.4 µM CaM before incubation with control r-synGAP (500 nM) for 60 min at 25° C. For 21 
comparison to Control, p = 0.7.  D, Stoichiometry of phosphorylation of r-synGAP by CaMKII. R-22 
synGAP (725 nM) was phosphorylated in the presence of CaMKII (10 nM), as described under 23 
“Materials and Methods.” At the indicated times, reactions were quenched by addition of 3x Laemmli 24 
sample buffer. Radiolabeled r-synGAP was isolated by SDS-PAGE and quantified as described under 25 
“Materials and Methods.” E, Change in affinity of r-synGAP for PDZ123 after phosphorylation by 26 
CaMKII for times corresponding to those measured in D. R-synGAP was phosphorylated for 0.5 to 10 27 
min as described in D before incubation with PDZ123 domain affinity resin for 60 min as described under 28 
“Materials and Methods.” Control (-CaMKII, -Ca2+/CaM) is r-synGAP incubated in the phosphorylation 29 
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reaction in the absence of CaMKII and Ca2+/CaM. For Caomparison of Control to phosphorylation for 30 
0.5, 1, 2, 5, or 10 min, p <0.0001.  Pairwise comparisons among all phosphorylation conditions showed 31 
no significant differences (p from 0.4 to 1).  Data shown in B-E are plotted as mean ± S.E. (n=4). For B, 32 
C, and E, the statistical significance of differences in binding to PDZ domain resin relative to 33 
unphosphorylated r-synGAP control (-Ca2+/CaM) was determined by ordinary one way ANOVA 34 
(uncorrected Fisher’s LSD). **, p<0.01; ***, p<0.001;  ****, p<0.0001.  35 
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 37 
FIGURE 1 -figure supplement 1. Purification of recombinant PDZ domains of PSD-95. PDZ domains 38 
of PSD-95 were expressed in E. coli individually or combined in a single peptide, as indicated, and 39 
purified as described under “Materials and Methods.” Proteins in the starting soluble fraction (S) and 40 
eluted from PDZ ligand affinity columns (E) were fractionated on 12% (PDZ1, PDZ2, PDZ3, PDZ12) or 41 
4-12% gradient (PDZ123) SDS-polyacrylamide gels and stained as described under “Materials and 42 
Methods.” 43 
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 45 
FIGURE 2. Measurement of affinity of r-synGAP for PDZ1 of PSD-95 by the “competition in solution” 46 
method. A, Biacore sensorgrams showing the calibration curves (grey lines) for binding of 0-50 nM r-47 
synGAP and the measurement of free r-synGAP (samples; black lines) in mixtures containing 25 nM r-48 
synGAP and 0-10 µM PDZ1 domain. Free r-synGAP was detected by binding to PDZ1 domains 49 
immobilized on a Biacore chip as described under Materials and Methods. B, A standard calibration curve 50 
was constructed by plotting the maximum calibrated resonance responses (marked by arrow in A) against 51 
the corresponding concentrations of r-synGAP (large grey dots). The maximum resonance responses for 52 
each sample mixture were plotted on the standard curve to determine the free r-synGAP concentrations in 53 
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each mixture (black dots). C, Plot of free r-synGAP concentrations determined in B against the log of 54 
PDZ domain concentrations (black circles). The data were fit to the binding equation shown in Materials 55 
and Methods with the use of Graphpad Prism software. A KD value (Table 1) was calculated from the 56 
equation as described under Materials and Methods. 57 
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 59 
FIGURE 3. Affinities and apparent affinities of r-synGAP for PDZ2, PDZ3, PDZ12 and PDZ123 60 
domains of PSD-95 determined by the “competition in solution” method. The concentrations of free r-61 
synGAP in sample mixtures containing each of the indicated PDZ domains were measured as described in 62 
Fig. 3A and B, and under Materials and Methods. The values (black dots) were plotted against the log of 63 
the PDZ domain concentration and fit to a binding curve as described in Fig. 3C. Representative 64 
experiment for A, PDZ2; B, PDZ3; C, PDZ12; and D, PDZ123.  The calculated  KD and KDapp values from 65 
all experiments are listed in Table 1. 66 
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 68 
FIGURE 4. Effect of phosphorylation by CaMKII on association of PDZ123 domains with phospho-69 
deficient and phospho-mimetic mutants of r-synGAP. Wild-type and mutant r-synGAP were incubated 70 
with phosphorylation mixtures for 10 min without (Control) or for 0.5 or 10 min with 10 nM CaMKII, 0.7 71 
mM CaCl2/3.4 µM CaM (CaMKII) then incubated with PDZ123 affinity resin for 60 min at 25° C, as 72 
described under “Materials and Methods.”  A, Binding of r-synGAP and r-synGAP mutants S1123A, 73 
S1123D, and S1099A/S1123A are represented by the indicated shades of grey bars. For comparison of 74 
WT to mutants after 0.5 min phosphorylation: S1123A, p = 0.001; S1123D, p = 0.04; S1093A/S1123A, p 75 
= 0.005. For comparison of WT to mutants after 10 min phosphorylation: S1123A, p = 0.625; S1123D, p 76 
= 0.437; S1093A/S1123A, p = 0.867. For comparison of WT and each mutant after 0.5 and 10 min 77 
phosphorylation: WT, p = 0.07; S1123A, p = 0.04; S1123D, p = 0.30; S1093A/S1123A, p = 0.366.  B, 78 
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Binding of r-synGAP and r-synGAP mutants S1283A and S1283D are represented by the indicated 79 
shades of grey bars. For comparison of WT to mutants before phosphorylation: S1283A, p = 0.2; 80 
S1283D, p <0.0001; For comparison of S1283A to S1283D, p = 0.0009. For comparison of WT to 81 
mutants after 0.5 min phosphorylation: S1283A, p =  0.0001; S1283D, p = 0.002. For comparison of WT 82 
and mutants after 0.5 and 10 min phosphorylation: WT, p = 0.2, S1283A, p = 0.001; S1283D, p = 0.007. 83 
Data are mean ± S.E. (n=4). The statistical significance of differences in PDZ domain binding among 84 
wild-type and mutant samples was determined by ordinary one way ANOVA (uncorrected Fisher’s LSD). 85 
*, p<0.05; **, p<0.01; ***, p<0.005;****, p<0.0001. 86 
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FIGURE 5. Apparent affinities of phosphorylated r-synGAP and r-synGAP-S1283D for PDZ123 90 
determined by the “competition in solution” method. Representative plots of the concentrations of (A) 91 
free phospho-r-synGAP phosphorylated as described for PDZ Binding Assays under Materials and 92 
Methods, and (B) r-synGAP-S1283D, measured in sample mixtures containing PDZ123 as described in 93 
Fig. 3A and B, and under Materials and Methods. The values (black dots) were plotted against the log of 94 
the PDZ123 concentration in the mixture and fit to a binding curve as described in Fig. 3C. The calculated 95 
KDapp values are listed in Table 1.   96 
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 97 
FIGURE 6. Effect of Ca2+/CaM on stoichiometry of phosphorylation of r-synGAP and Histone H1 by 98 
CDK5. Stoichiometry of phosphorylation of r-synGAP (A-B) and Histone H1 (C-D) by CDK5/p35 or 99 
CDK5/p25. R-synGAP (286 nM) or Histone H1 (4.3 µM) were incubated with CDK5/p35 or CDK5/p25 100 
as described uner “Materials and Methods” in the presence or absence of 0.7 mM CaCl2  or 3.4 µM CaM, 101 
as indicated in each panel. Reactions were quenched at the indicated times by addition of 3x Laemmli 102 
sample buffer and radiolabeled r-synGAP and Histone H1 were quantified as described under Materials 103 
and Methods.  For comparison of phosphorylation in the presence and absence of Ca2+/CaM: A) 10 min, p 104 
= 0.01; 30 min, p <0.0001; 60 min, p <0.0001. B) 10 min, p = 0.001; 30 min, p <0.0001, 60 min,  p < 105 
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0.0001. C) 0.5 min, p = 0.5; 1 min, p = 0.9; 2 min, p = 0.4. D) 0.5 min, p = 0.5; 1 min, p =  0.3; 2 min, p = 106 
0.2. Data are plotted as mean ± S.E. (n = 4-7). The statistical significance of differences in 107 
phosphorylation in the presence of Ca2+ and CaM were determined by ordinary one way ANOVA 108 
(uncorrected Fisher’s LSD). **, p<0.01; ***, p<0.001; ****, p<0.0001. 109 
  110 
peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/058016doi: bioRxiv preprint first posted online Jun. 9, 2016; 
 40 
 111 
FIGURE 6 - figure supplement 1. R-synGAP binds to CaM affinity resin. Clarified E. coli lysate (Load) 112 
containing r-synGAP was incubated with CaM-Sepharose 4B or control Sepharose 4B resin in the 113 
presence of 0 or 5 mM CaCl2 and 0 or 10 mM EGTA, as described under “Materials and Methods.”  114 
After washing, bound protein was eluted from the resin with 100 mM EGTA (Eluate), fractionated by 115 
SDS-PAGE, and visualized by staining with Gel Code Blue (Total Protein) or transferred to a PVDF 116 
membrane. R-synGAP was detected on the immunoblots with anti-synGAP or anti-TetraHis antibodies, 117 
as described under “Materials and Methods.” In the absence of exogenous calcium, r-synGAP bound 118 
weakly to the CaM-Sepharose, but not to control Sepharose beads. When 5 mM Ca2+ was included in the 119 
binding and wash buffers its binding to CaM-Sepharose increased, while addition of 10 mM EGTA to the 120 
buffers nearly abolished binding.  121 
  122 
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Figure 6 - figure supplement 2. Effect of binding of Ca2+/CaM on GAP activity of r-synGAP. The GAP 125 
activity of r-synGAP (250 nM) for the indicated GTP-binding protein was assayed as described in 126 
Walkup et al.  (2015) except that 1 mM Ca2+, 3.4 µM CaM, or both were added to the GAP assay as 127 
indicated. A,  HRas GAP activity; B, Rap1 GAP activity; and C. Rap2 GAP activity. Data are mean ± S.E. 128 
The statistical significance of differences between activity in the presence of r-synGAP in the absence of 129 
Ca2+ or CaM (second column) and all other conditions was determined by ordinary one way ANOVA 130 
(uncorrected Fisher’s LSD). ****, p<0.0001. For comparison of GAP activities in the absence and 131 
presence of synGAP: HRas, Rap1 or Rap2, p < 0.0001.  For comparisons of reactions containing 132 
synGAP: HRas, p ranged from 0.3 to 0.9; Rap1, p ranged from 0.5 to 0.7; Rap2, p ranged from 0.5 to 0.6.   133 
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 135 
FIGURE 7. Affinity of r-synGAP for Ca2+/CaM determined by equilibrium analysis. (A-B) The 136 
affinity of r-synGAP for Ca2+/CaM was measured by SPR with CaM immobilized on the chip and r-137 
synGAP injected at 0-50 nM onto the chip surface as described under Materials and Methods. A, 138 
Sensorgrams with the blank and reference flow cell readings subtracted show the response upon injection 139 
of r-synGAP onto the chip surface (0-75 seconds) and its dissociation from the chip surface (75-150 140 
seconds). B, RUs at equilibrium (marked by arrow in A) were plotted against the corresponding 141 
concentrations of r-synGAP and fitted to a hyperbolic curve. A KD of 9 ± 1 nM was calculated as described 142 
under Materials and Methods. C and D, The affinities of r-synGAP and sr-synGAP (0-500 nM) for 143 
Ca2+/CaM were measured by incubation with CaM-Sepharose resin as described under Materials and 144 
Methods. Integrated intensities of bound r- and sr-synGAP were measured from immunoblots as described 145 
under Materials and Methods and plotted versus the corresponding concentrations incubated with resin. 146 
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Integrated intensities from Western blots were linear over the range of r- and sr-synGAP concentrations 147 
used in the assays C, r-synGAP; and D, sr-synGAP. Data in C and D are plotted as mean ± S.E. (n = 3). 148 
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 150 
FIGURE 8. Effect of Ca2+/CaM binding on association of r-synGAP with PDZ domains of PSD-95.  151 
A, Association of control and Ca2+/CaM bound r-synGAP with PDZ domains of PSD-95. R-synGAP (500 152 
nM) without (Control) or with (+ CaM) 0.7 mM CaCl2/3.4 µM CaM was incubated with PDZ domain 153 
resins (PDZ1, PDZ2, PDZ3, PDZ12, and PDZ123) for 60 min at 25° C and bound synGAP was measured 154 
as described under Materials and Methods. For comparison of control to +Ca2+/CaM, PDZ1, p = 0.09; 155 
PDZ2, p = 0.2; PDZ3, p = 0.003 (d = 1.9); PDZ12, P = 0.7; PDZ123, p = 0.0001 (d = 2.6). B, Effects of 156 
bound Ca2+/CaM and phosphorylation by CaMKII on association of r-synGAP with PDZ123 domain are 157 
not additive. The association of synGAP with PDZ123 domain resin was measured as in A, under four 158 
different conditions:  (Control), unphosphorylated r-synGAP alone; (plus CaM), Ca2+/CaM present in 159 
excess of synGAP during the incubation with resin; (plus CaMKII),  r-synGAP is prephosphorylated with 160 
CaMKII as described under Materials and Methods, then Ca2+ is chelated with EGTA during the 161 
incubation with resin; and (plus CaM and CaMKII), r-synGAP is prephosphorylated by CaMKII and 162 
Ca2+/CaM is present in excess during incubation with resin.  For comparison to Control: plus CaM, p 163 
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<0.0001; plus CaMKII, p <0.0001; plus CaM and CaMKII, p <0.0001.  For camparison of “plus CaMKII” 164 
and “plus CaM and CaMKII” samples, p = 0.06.  Data are plotted as mean ± S.E. (n=4). The statistical 165 
significance of differences in PDZ domain binding relative to Control was determined by ordinary one way 166 
ANOVA (uncorrected Fisher’s LSD). **, p<0.01; ****, p<0.0001.  167 
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 169 
Figure 9. Altered composition of the postsynaptic density in mice with heterozygous deletion of 170 
synGAP.  Ratios of amounts of the indicated proteins to PSD-95 were measured as described in Materials 171 
and Methods and are reported as mean ± S.E. For all blots except those for neuroligin-1, PSD-95 was 172 
detected with a secondary Ab labelled with AlexaFluor680 and the binding protein was detected with 173 
secondary Ab labelled with IRDye 800. On the neuroligin-1 blot, both PSD-95 and neuroligin-1 were 174 
detected with AlexaFluor680; the two bands were well-separated in each lane. Representative sets of 175 
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visualized bands for wild-type (WT) and synGAP-/+ (HET) from the same blot are shown below the graphs.  176 
A, SynGAP to PSD-95 ratio. Data were collected for 22 lanes from two blots containing 5 µg total PSD 177 
fraction per lane. One blot contained six lanes WT and six lanes HET samples, the other contained five 178 
lanes of each. The mean ratio of synGAP to PSD-95 was 0.234 ± 0.012 for WT (n = 11) and 0.179 ±0.005 179 
(n = 11) for HET. Means were compared by unpaired, one-tailed t-test with Welch correction, p = 0.0007, 180 
d = 1.75.  B, TARP ɣ -2,3,4,8 to PSD-95 ratio. Data were collected for 24 lanes from two blots containing 181 
10 µg total PSD fraction per lane.  Each blot contained six lanes WT and six lanes HET samples. Densities 182 
of all four TARPs were pooled. The mean ratio of TARPs to PSD-95 was 0.066 ±0.003 (n = 12) for WT 183 
and  0.075 ±0.003 (n = 12) for HET.  Means were compared by unpaired, one-tailed t-test with equal 184 
variance, p = 0.017, d = 0.93.  C, LRRTM2 to PSD-95 ratio. Data were collected  for 36 lanes from three 185 
blots containing six WT and six HET samples, alternating 5 and 10 µg (3 each).  The mean ratio of 186 
LRRTM2 to PSD-95 was 0.051 ±0.003 for WT (n = 17) and 0.059 ±0.003 for HET (n = 17). Means were 187 
compared by paired, one-tailed t-test, p=0.0035, d = 0.66.  D, Neuroligin-1 to PSD-95 ratio. Data were 188 
collected for 47 lanes from four blots two of which contained 5 µg and two 10 µg total PSD fraction per 189 
sample. Each blot contained six lanes WT and six lanes HET samples. The mean ratio of neuroligin-1 to 190 
PSD-95 was 0.114 ±0.005 (n = 24) for WT and  0.115 ± 0.004 (n = 23) for HET.  Means were compared 191 
by unpaired one-tailed t-test, p = 0.413, d = 0.07.  E, Neuroligin-2 to PSD-95 ratio. Data were collected for 192 
44 lanes from four blots containing 10 µg total PSD fraction per lane. Each blot contained six lanes WT 193 
and six lanes HET samples. The mean ratio of neuroligin-2 to PSD-95 was 0.071 ±0.002 (n = 20) for WT 194 
and  0.078 ± 0.003 (n = 24) for HET. Means were compared by unpaired, one-tailed t-test with Welch 195 
correction, p= 0.019, d = 0.64.  *, p<0.05; **, p<0.01; ***, p<0.001 196 
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 198 
FIGURE 10.  Cartoon model of rearrangement of PSD after phosphorylation of synGAP by CaMKII.  199 
A,  Unphosphorylated synGAP binds to PDZ1, PDZ2 or PDZ3 of PSD-95, occupying as many as ~30% 200 
of its PDZ domains.  The PDZ domains of PSD-95 are shown in blue and their numbers are indicated on 201 
the left pair of PSD-95 molecules.  AMPARs that have been inserted into the extrasynaptic membrane by 202 
exocytosis associate with TARPs and with LRRTMs, both of which can bind to PDZ1 and PDZ2 of PSD-203 
95. Neuroligin-1 (NLG1) binds to PDZ3 of PSD-95. LRRTMs and NLG1 also bind across the synaptic 204 
cleft to presynaptic neurexins.  B, Calcium flux through NMDARs activates CaMKII leading to 205 
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phosphorylation of synGAP on sites in the regulatory domain. The affinity of synGAP for the PDZ 206 
domains decreases, allowing TARPs, LRRTMs, and NLG-2 to displace synGAP by binding to the PDZ 207 
domains.  The shift in affinity of synGAP creates “slots” that can be occupied by AMPAR complexes, or 208 
by neuroligin-2, leading to strengthening of the synapse.  209 
210 
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TABLE 1.  Affinities of R-synGAP for PDZ Domains of PSD-95 211 
Dissociation constants (KD or KDapp) for the interactions of synGAP with PDZ domains of PSD-95 212 
were determined by the Biacore/SPR “competition in solution” method as described under “Materials and 213 
Methods.”  In one experiment, the KD for PDZ3 was determined by conventional SPR as described under 214 
“Materials and Methods.”  Goodness of Fit refers to the fit of the data shown in Figs. 2, 3, and 5 to the 215 
equation relating synGAPfree to PDZ domain concentration described under “Materials and Methods.”  216 






Dissociation Constant (KD) for Binding 
 r-synGAP (nM) Goodness of Fit (R
2)  
PDZ1 3 220 + 30 0.908 - 0.947 
PDZ2 2 1500 + 100 0.967, 0.969 
PDZ3 2 620 + 70 0.951, 0.9624 
PDZ3 1 730 + 50 (by conventional SPR) N.A. 
  Apparent Dissociation Constant (KDapp) for 
Binding to R-synGAP (nM) 
 
PDZ12 4 350 +  40 0.931 - 0.987 
PDZ123 6 4.7 + 0.6 0.957 - 0.985 
PDZ123 3 (CaMKII Phosphorylated r-synGAP) 46 + 10  0.810 - 0.880 
PDZ123 2 (S1283D r-synGAP) 16 + 3  0.953, 0.954 
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